PM
BMY icon

Prosight Management’s Bristol-Myers Squibb BMY Stock Holding History

Prosight Management’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-50,000
Closed -$2.94M – 50
2020
Q2 		$2.94M Buy
+50,000
New +$2.99M 1.26% 24

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Prosight Management's BMY Position: Q2 2021 in Review

Prosight Management sold out of Bristol-Myers Squibb (BMY) in Q2 2021, closing a stake of 95,600 shares — an estimated $6.04M sold.

Prosight Management first reported a position in BMY in Q1 2019 and held it in 8 quarters. The position peaked at $18.6M in Q2 2019. 2,370 funds tracked by Wall St. Rank hold BMY as of Q2 2021.

  • Prosight Management reported no remaining Bristol-Myers Squibb position as of Q2 2021 after selling out during the quarter.
  • Prosight Management sold 95,600 Bristol-Myers Squibb shares in Q2 2021, an estimated $6.04M.
  • Prosight Management first reported a position in Bristol-Myers Squibb in Q1 2019 and held it in 8 quarters.
  • Prosight Management's Bristol-Myers Squibb position peaked at $18.6M in Q2 2019.
  • 2,370 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2021.

Based on Prosight Management's 13F filing for Q2 2021, filed 13 Aug 2021.